Jon Brett-Harris is Executive Vice President of the Pharmaceutical and Chemistry Markets strategic business unit for Thomson Scientific. His responsibilities include the Liquent, IDRAC, Newport, Astrolabe PIA and CMR businesses.
Prior to joining Thomson in March 2006, Jon held management and leadership roles within the pharmaceutical and biotechnology industry. He had also operated his own company with activities focused on pharmaceutical licensing, venture funding and executive coaching.
Jon holds a Bachelor of Science degree in Psychology and Economics and an MBA, both from the University of London.
|